This is a routine commercial expansion with no disclosed financial impact. Monitor future quarterly filings for any revenue contribution from this partnership, but the announcement alone does not warrant a trading action.
Price Chart
Executive Summary
Pulsenmore announced that its home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at Ichilov, a major Israeli medical center, expanding its presence in central Israel. This is a routine commercial expansion announcement with no financial terms disclosed, representing incremental adoption of an existing product within the company's home market. The filing contains no revenue, earnings, or financial guidance figures.
Key Facts
- Pulsenmore's home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at Ichilov in Israel.
- The expansion adds to existing partnerships including Clalit Health Services and several hospitals.
- No financial terms, revenue projections, or volume commitments were disclosed in the filing.
- The company's activities in Israel now encompass three models: nationwide service via Clalit, Hospital at Home, and hybrid high-risk pregnancy monitoring.
Financial Impact
No financial figures disclosed; immaterial commercial expansion within existing market
Risk Factors
- No revenue or volume commitments disclosed — commercial impact is unquantifiable
- Company has limited operating history and is pre-revenue or early-revenue stage per its own risk factors
- Forward-looking statements about commercial potential carry execution risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-039108 |
| Exhibit: ex99-1.htm | 0001493152-26-039108 |
| Document: 0001493152-26-039108-index-headers.html | 0001493152-26-039108 |
| Document: 0001493152-26-039108-index.html | 0001493152-26-039108 |
| Document: 0001493152-26-039108.txt | 0001493152-26-039108 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.90 | awaiting T+20 | — | $1.73 (−8.95%) |
Oct 8, 2026 18d ago | SC 13G | $1.85 | awaiting T+20 | — | $1.73 (−6.49%) |
Sep 17, 2026 5w ago | 6-K | $2.42 $1.81 | ▼ −25.21% | ▼ −26.41% | $1.73 (−28.51%) |
Sep 8, 2026 6w ago | 6-K | $2.46 $2.16 | ▼ −12.20% | ▼ −13.91% | $1.73 (−29.67%) |
Sep 2, 2026 7w ago | EFFECT | $2.55 $2.22 | ▲ +12.94% | ▲ +12.86% | $1.73 (+32.16%) |
Aug 31, 2026 8w ago | 6-K | $2.62 $2.19 | ▼ −16.41% | ▼ −16.22% | $1.73 (−33.97%) |
Aug 19, 2026 9w ago | 6-K | $3.01 $2.42 | ▼ −19.60% | ▼ −18.76% | $1.73 (−42.52%) |
Aug 17, 2026 10w ago | 6-K | $2.89 $2.41 | ▼ −16.61% | ▼ −14.63% | $1.73 (−40.14%) |
Jul 13, 2026 15w ago | 6-K | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
Jul 13, 2026 15w ago | EFFECT | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers